Tissue-Specific Oncogenic Activity of KRAS<SUP>A</SUP><SUP>146</SUP><SUP>T</SUP>



Poulin, Emily J, Bera, Asim K, Lu, Jia, Lin, Yi-Jang, Strasser, Samantha Dale, Paulo, Joao A, Huang, Tannie Q, Morales, Carolina, Yana, Wei, Cook, Joshua
et al (show 19 more authors) (2019) Tissue-Specific Oncogenic Activity of KRAS<SUP>A</SUP><SUP>146</SUP><SUP>T</SUP>. CANCER DISCOVERY, 9 (6). pp. 738-755.

[img] Text
210474_2_merged_pdf_5429261_pp59pd.pdf - Author Accepted Manuscript

Download (925kB) | Preview

Abstract

<i>KRAS</i> is the most frequently mutated oncogene. The incidence of specific <i>KRAS</i> alleles varies between cancers from different sites, but it is unclear whether allelic selection results from biological selection for specific mutant KRAS proteins. We used a cross-disciplinary approach to compare KRAS<sup>G12D</sup>, a common mutant form, and KRAS<sup>A146T</sup>, a mutant that occurs only in selected cancers. Biochemical and structural studies demonstrated that KRAS<sup>A146T</sup> exhibits a marked extension of switch 1 away from the protein body and nucleotide binding site, which activates KRAS by promoting a high rate of intrinsic and guanine nucleotide exchange factor-induced nucleotide exchange. Using mice genetically engineered to express either allele, we found that KRAS<sup>G12D</sup> and KRAS<sup>A146T</sup> exhibit distinct tissue-specific effects on homeostasis that mirror mutational frequencies in human cancers. These tissue-specific phenotypes result from allele-specific signaling properties, demonstrating that context-dependent variations in signaling downstream of different KRAS mutants drive the <i>KRAS</i> mutational pattern seen in cancer. SIGNIFICANCE: Although epidemiologic and clinical studies have suggested allele-specific behaviors for <i>KRAS</i>, experimental evidence for allele-specific biological properties is limited. We combined structural biology, mass spectrometry, and mouse modeling to demonstrate that the selection for specific KRAS mutants in human cancers from different tissues is due to their distinct signaling properties.<i>See related commentary by Hobbs and Der, p. 696</i>.<i>This article is highlighted in the In This Issue feature, p. 681</i>.

Item Type: Article
Uncontrolled Keywords: Humans, Neoplasms, Cell Transformation, Neoplastic, Proteome, Proteomics, Organ Specificity, Protein Conformation, Structure-Activity Relationship, Phenotype, Mutation, Alleles, Oncogenes, Models, Molecular, Proto-Oncogene Proteins p21(ras)
Depositing User: Symplectic Admin
Date Deposited: 28 Jun 2019 07:06
Last Modified: 19 Oct 2023 08:55
DOI: 10.1158/2159-8290.CD-18-1220
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3047695